Hydroxychloroquine for inflammatory heart muscle weakness
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests hydroxychloroquine to see if it improves symptoms and heart function in people with inflammatory cardiomyopathy (inflammation of the heart muscle). It’s mainly for adults with a specific type of past myocarditis and ongoing heart failure despite standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 80 years old
- Your latest heart ultrasound shows weak pumping (left ventricular ejection fraction under 50%) within 30 days
- You have long-lasting heart failure (more than 6 months) despite usual supportive treatments
- Your blood tests show heart stress/injury markers above study thresholds (hs-troponin I and NT-proBNP)
- You’ve had confirmed fulminant myocarditis in the past, and an endomyocardial biopsy confirmed chronic inflammatory cardiomyopathy
- You’re able to take study medicines and give informed consent (and you’re not pregnant or breastfeeding)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug colchicine can help people with heart muscle inflammation (myocarditis) that also causes abnormal heart rhythms, a weak heart pump, or high stress markers. Colchicine is an anti-inflammatory medicine that might reduce heart damage and improve symptoms.
This study is creating a national registry to learn more about inflammatory myocardial disease (inflammation of the heart muscle). If you have symptoms like chest pain, shortness of breath, palpitations, or certain test results, you may be eligible to join and help advance research.
This study looks at people 18 and older with suspected myocarditis (inflammation of the heart). It uses an inner-heart biopsy and tailored treatment based on the likely cause to improve diagnosis and care, especially for people with different heart rhythm or non-rhythm symptoms.
This study uses heart scans (MRI or nuclear imaging) to better understand inflammatory heart conditions. If you have a suspected inflammatory heart disease and are already scheduled for one of these scans, you may be able to join.
This trial tests whether steroids (corticoids) can improve recovery in people with acute myocarditis, which is inflammation of the heart muscle. If you have been recently diagnosed and your heart isn't pumping as well as it should, this treatment might help reduce inflammation and improve heart function.
This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.
Hear when a new Inflammatory Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.